Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Clinical Study of Safety, Tolerability, and Pharmacokinetics / Pharmacodynamics of Single and Multiple Ascending Doses of PSTB100 Tablets in Healthy Adult Subjects

NCT07702279 is registered in ClinicalTrials.gov with Prospect Therapeutics (Nanjing) Limited as lead sponsor.

NCT NCT07702279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07702279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Clinical Study of Safety, Tolerability, and Pharmacokinetics / Pharmacodynamics of Single and Multiple Ascending Doses of PSTB100 Tablets in Healthy Adult Subjects
Lead sponsor
Prospect Therapeutics (Nanjing) Limited
Phase
Phase 1
Overall status
Recruiting
Start date
July 14, 2026
Completion date
September 6, 2027
Enrollment
68 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult subjects